Does RAVULIZUMAB-CWVZ Cause Symptom recurrence? 221 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 221 reports of Symptom recurrence have been filed in association with RAVULIZUMAB-CWVZ. This represents 2.2% of all adverse event reports for RAVULIZUMAB-CWVZ.
221
Reports of Symptom recurrence with RAVULIZUMAB-CWVZ
2.2%
of all RAVULIZUMAB-CWVZ reports
0
Deaths
10
Hospitalizations
How Dangerous Is Symptom recurrence From RAVULIZUMAB-CWVZ?
Of the 221 reports, 10 (4.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Symptom recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 221 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Symptom recurrence?
NIRMATRELVIR\RITONAVIR (990)
DUPILUMAB (399)
SECUKINUMAB (367)
EFGARTIGIMOD ALFA-FCAB (163)
ADALIMUMAB (162)
OMALIZUMAB (129)
ECULIZUMAB (128)
TEPROTUMUMAB-TRBW (118)
ARIPIPRAZOLE (115)
METHOTREXATE (114)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Symptom recurrence Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST